FDA Drug Recalls

Recalls / Class II

Class IID-1348-2015

Product

univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

Affected lot / code info
Lot #: 98016P1, Expiry: April, 2016

Why it was recalled

Failed Dissolution Testing: Failed 24 month dissolution testing.

Recalling firm

Firm
Ucb, Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1950 Lake Park Dr Se, Smyrna, Georgia 30080-7648

Distribution

Quantity
2,916 Bottles
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2015-07-24
FDA classified
2015-08-19
Posted by FDA
2015-08-26
Terminated
2017-07-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1348-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls